|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,383.00 JPY | +1.35% |
|
+4.16% | +5.69% |
| 11-21 | Meiji Holdings Co., Ltd., Q2 2026 Earnings Call, Nov 13, 2025 | |
| 11-20 | Meiji Holdings Transfers KM Biologics Stake to Pharma Unit in Group Restructuring | MT |
| Capitalization | 917B 5.87B 5.04B 4.71B 4.4B 8.12B 527B 8.83B 54.61B 21.28B 250B 22.01B 21.54B | P/E ratio 2026 * |
16.8x | P/E ratio 2027 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise value | 955B 6.11B 5.24B 4.9B 4.58B 8.45B 549B 9.2B 56.87B 22.16B 260B 22.92B 22.44B | EV / Sales 2026 * |
0.81x | EV / Sales 2027 * | 0.8x |
| Free-Float |
85.07% | Yield 2026 * |
3.1% | Yield 2027 * | 3.25% |
Last Transcript: Meiji Holdings Co., Ltd.
| 1 day | +1.35% | ||
| 1 week | +4.16% | ||
| Current month | +0.42% | ||
| 1 month | +9.62% | ||
| 3 months | +5.95% | ||
| 6 months | +5.69% | ||
| Current year | +5.69% |
| 1 week | 3,212 |  | 3,407 |
| 1 month | 3,079 | | 3,407 |
| Current year | 2,871 | | 3,628 |
| 1 year | 2,871 | | 3,628 |
| 3 years | 2,871 | | 3,837 |
| 5 years | 2,871 | | 3,837 |
| 10 years | 2,871 | | 5,465 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 68 | 26/06/2025 | |
Hayato Shimada
ADM | Chief Administrative Officer | - | - |
| Corporate Officer/Principal | - | 26/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Furuta
BRD | Director/Board Member | 68 | 31/05/2014 |
| Director/Board Member | 68 | 27/06/2018 | |
Mariko Matsumura
BRD | Director/Board Member | 66 | 27/06/2018 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 4.06% | 23 M€ | +8.99% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.35% | +4.16% | +7.50% | +0.39% | 5.77B | |
| -0.18% | -1.51% | +2.92% | -28.77% | 249B | |
| -0.41% | -3.75% | -12.29% | -19.64% | 69.82B | |
| +0.72% | -1.48% | -7.02% | -23.95% | 36.25B | |
| +2.48% | -1.07% | +229.11% | +453.19% | 30.68B | |
| -0.01% | +0.37% | +3.55% | +15.34% | 29.03B | |
| +0.50% | -2.44% | -23.23% | -39.03% | 28.68B | |
| +0.24% | -3.48% | +11.99% | -36.65% | 27.91B | |
| -0.55% | -3.97% | +8.43% | +19.39% | 26.08B | |
| +0.15% | -1.06% | -30.89% | -47.36% | 24.35B | |
| Average | +0.50% | -1.55% | +19.01% | +29.29% | 52.74B | |
| Weighted average by Cap. | +0.13% | -1.79% | +11.24% | +4.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,176B 7.52B 6.46B 6.04B 5.64B 10.41B 676B 11.33B 70.02B 27.28B 320B 28.22B 27.62B | 1,202B 7.69B 6.6B 6.17B 5.77B 10.64B 691B 11.58B 71.57B 27.89B 328B 28.85B 28.24B |
| Net income | 54.46B 348M 299M 280M 261M 482M 31.31B 525M 3.24B 1.26B 14.84B 1.31B 1.28B | 58.35B 373M 320M 300M 280M 517M 33.54B 562M 3.47B 1.35B 15.9B 1.4B 1.37B |
| Net Debt | 37.95B 243M 208M 195M 182M 336M 21.82B 366M 2.26B 881M 10.34B 911M 891M | 41.18B 263M 226M 211M 198M 364M 23.67B 397M 2.45B 955M 11.22B 988M 967M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 3,383.00 ¥ | +1.35% | 1,995,200 |
| 09/12/25 | 3,338.00 ¥ | +0.54% | 1,412,600 |
| 08/12/25 | 3,320.00 ¥ | +2.69% | 1,849,500 |
| 05/12/25 | 3,233.00 ¥ | -0.83% | 1,447,600 |
| 04/12/25 | 3,260.00 ¥ | 0.00% | 1,544,700 |
Delayed Quote Japan Exchange, December 10, 2025 at 06:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2269 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition